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 ABSTRACT 
In Physcomitrella patens, actin-mediated trafficking and myosin XIa are essential for 
polarized growth. In other model organisms, the association between myosin and its cargo is 
mediated by Rab-GTPases. We cloned and purified wild type and mutants of moss myosin XIa 
that fail to complement an RNAi myosin XIa loss-of-polarity phenotype. Through binding 
assays, we identified RabA21 as having potential myosin XIa binding activity. The disruption of 
this interaction may be responsible for the lack of rescue of the phenotype.
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 1.0 INTRODUCTION AND BACKGROUND 
1.1 POLARIZED GROWTH 
In the eukaryotic cell, the organization of proteins, membranes, and organelles allows for 
many complex processes to occur. In fact, directed movement and the resulting organization is 
essential for life (Wickner, 2008). The processes of cell growth and division, in particular, rely 
upon the directed movement and organization of various components. When cells grow in a 
polarized fashion, or in one specific direction rather than uniformly, the need for various 
materials to be brought to the growing tip of the cell requires subcellular organization.  
Many types of cells undergo the process of polarized cell growth and therefore are key 
systems for understanding the molecular mechanisms by which their respective subcellular 
organization is accomplished.  In mammalian systems, epithelial, neuronal, and many other types 
of cells undergo polarized growth. For example, epithelial cells grow towards the apical and 
basal sides of the cell. Neurons extend only at the apex of the cell by using the cytoskeletal 
matrix and calcium signaling to form synapses. In plants, pollen tube cells and root hairs from 
vascular plants, and protonemal cells from bryophytes also experience this phenomenon. The 
ability of these cells to extend extraordinarily in length relative to their width not only requires 
coordinated growth, but also confers unique function. For example, plant pollen tubes experience 
extremely rapid polarized growth (250 nm/s in lilies) so that they can search for an ovule, which 
allows for fertilization and sexual reproduction to occur (Cole and Fowler, 2006). Furthermore, 
plant root hairs utilize polarized growth (10-40 nm/s) to obtain minerals and water from the soil 
that are critical for the growth of the plant (Vidali and Hepler, 2001). 
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The process of polarized growth, and the proteins needed to coordinate the process, are 
conserved from singled celled eukaryotes to the multicellular organisms described previously. 
For example, budding yeast, the traditional model organism for studying polarized growth, 
divides when the daughter yeast cell grows and buds off the mother yeast cell at a specific 
location along the plasma membrane. The coordination of the cytoskeletal network, molecular 
motors, and effectors allows for the creation of the gradients needed for polarized growth 
(Pruyne D., 2000). One species that experiences polarized cell growth is Physcomitrella patens, 
a species of moss traditionally used as a model system to study plant evolution and development. 
1.2 PHYSCOMITRELLA PATENS 
 The bryophyte, Physcomitrella patens, can also be used as a model system for studying 
polarized growth, specifically tip growth.  The tissues in the moss, P. patens, which grow in a 
polarized fashion are protonemata, including chloronemata and caulonemata (Menand et al., 
2007). Chloronemata are the most basic cell type in P. patens and are characterized by a 
perpendicular cell wall and a large number of chloroplasts. Chloronemata grow at a rate of 1.5 
nm/s and divide approximately every 24 hours (Vidali and Bezanilla, 2012).  By contrast, 
caulonemal cells have oblique cell walls and fewer chloroplasts.  Caulonemata grow at a rate of 
5-10 nm/s and divide every 7 hours.  Growing caulonemal cells also have tips that are lacking 
large organelles, but are instead filled with material needed for cell wall deposition and cell 
growth (Cove and Knight, 1993). Materials for polarized tip growth are transported through the 
cell’s cytoskeleton network through trafficking along actin. P. patens is a useful model system 
due to its ability to be genetically modified, and its pluripotency (Vidali and Bezanilla, 2012).  
Genetic modifications occur using homologous recombination, which in P. patens can happen 
with up to 100% frequency, whereas in flowering plants, it occurs at a rate of 10-4-10-5 (Kamisugi 
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et al., 2006).  This makes P. patens ideal for knock-outs, knock-ins, and RNA interference 
(RNAi) strategies (Kamisugi et al., 2006). The genome of P. patens has been sequenced, which 
makes genetic manipulations easier as well (Rensing et al., 2008). Physcomitrella patens is also 
ideal for microscopy because of the large cell size and organization into a monolayer.   
1.3 ACTIN CYTOSKELETON 
Many eukaryotic cells, including the protonemata of P. patens, use cytoskeletal networks 
to orchestrate subcellular polarization. Cytoskeletal networks in plants cells, including those of 
P. patens, are composed of microtubules and actin filaments. Discovered in muscle tissues in the 
1940s, cellular concentrations of actin make it one of the most ubiquitous and abundant proteins 
(Pollard T.D., 2009).  
In many types of cells, actin monomers polymerize into long, stable filaments that act as 
subcellular pathways for the trafficking of proteins. Actin filaments grow in a polarized fashion 
by adding ATP-actin monomers on one end (barbed end), hydrolyzing the gamma phosphate, 
and leading to the dissociation of the ADP-actin monomer on the opposite end (pointed end). 
Over 100 accessory proteins control the polymerization of actin, including regulating elements 
such as the length, the turnover, and branching of actin filaments (Pollard T.D., 2009). One class 
of proteins that utilize the actin cytoskeletal network are myosin motors, which interact with 
actin to create the mechanical force necessary to transport various cargos throughout the cell. 
In P. patens, the material transported along the actin cytoskeleton is hypothesized to be 
necessary for polarized cell growth to the tip of the cell.  Figure 1 shows a model illustrating the 
cell machinery thought to be used in this process. 
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Figure 1: Model for tip growth in P. patens (Vidali and Bezanilla, 2012). 
In this model, actin is polymerizing and depolymerizing near the cell membrane.  This 
process is regulated by the basal machinery of profilin, actin depolymerizing factor, and class II 
formin, which binds to PI(3,5)P2.  The motor protein myosin XIa is then able to move down the 
existing actin filament, carrying the cargo needed to continue growth (Vidali and Bezanilla, 
2012).   
1.4 MYOSIN MOTORS 
Myosins belongs to a family of motor proteins that are involved in many different cellular 
processes including organelle trafficking, cytokinesis, maintenance of cell shape, muscle 
contraction, and polarized growth (Scholey J. M., 2003; Vale, 2003; Yumura S., 2003; Geeves, 
2005; Vidali et al., 2010). Phylogenetic analysis of myosins reveals 35 classes, making them one 
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of the most prevalent and divergent families of proteins (Bernardo J. Foth, 2006; Maravillas-
Montero J., 2012). Most myosins utilize actin filaments by using the energy of ATP hydrolysis to 
“walk” towards the barbed end of the filament with defined step sizes that vary between myosin 
classes.   
In P. patens, the functionally redundant proteins myosin XIa and myosin XIab are the 
homologues of animal and yeast class V myosin. These proteins are hypothesized to function as 
processive molecular motors carrying various cargoes along actin filaments and organizing cells. 
The protein, which has a molecular weight of 174.34 kDa, dimerizes and consists of four 
domains is shown in Figure 2 (Vidali et al., 2010).  
The head domains, also termed the motor domains, bind to actin filaments to generate the 
mechanical force of the motor via the hydrolysis of ATP. Two head domains are attached to two 
neck domains, which consist of six IQ calmodulin binding motifs each. The neck domains 
connect to the coiled-coil domain, which is required for the dimerization of myosin XIa in vivo. 
The final domain on the C terminus is the globular tail domain (GTD), also called the cargo 
Globular tail domain (cargo binding) 
Coiled-coil (dimerization) 
Neck  
Head (motor domain) 
Figure 2: Schematic of P. patens myosin XIa [Adapted from (Goodsell, 2001)] 
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binding domain (CBD). This domain allows class V myosins to specifically bind various 
cargoes, including secretory vesicles. The cargo binding domain as well as a small portion of the 
coiled-coil domain (64 amino acids) is soluble and can be purified (Jacques, 2013).  
In P. patens, there are two functionally redundant isoforms of myosin XIa: myosin XIa 
and myosin XIab. In the caulonemal and chloronemal cells of P. patens, myosin XIa is necessary 
for normal polarized growth, as a knockdown of both isoforms of myosin XIa inhibits polarized 
growth. In protonemal cells, myosin XIa travels along actin filaments, localizing to the growing 
tip of the cell (Vidali et al., 2010).   
The GTD of class V myosins plays a role in selective cargo recruitment of the molecular 
motor and the regulation of motor activity. The GTD is also known to interact both directly and 
indirectly with various other proteins, including Rab GTPases. The GTD itself contains two 
subdomains which have been shown in mammalian Myo5B, the homologue of myosin XIa, to 
allow for the selective binding of different cargoes (Pashkova et al., 2005; Pylypenko, 2013). 
1.5 RAB GTPASES 
Many proteins are necessary for regulating membrane traffic.  The Rab family of small 
GTPases typically activate the transport of vesicles and the recognition, tethering, and fusion of 
vesicles to their target compartment. Rab proteins are molecular switches which are prenylated 
on their C-terminal domain to insert into the target membrane.  These proteins are activated and 
deactivated by their nucleotide state, which is controlled by additional proteins: guanine 
nucleotide exchange factors (GEFs) that replace GDP with GTP to activate them, and GTPase-
activating proteins (GAPs) that activate the Rab’s hydrolysis of GTP to GDP, to deactivate them.  
Additionally, Rab GDP dissociation inhibitors (Rab GDI) bind to a Rab in the GDP form and 
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prevent the dissociation of GDP.  This allows the Rab to be reactivated off the membrane by the 
GEF and re-bound to a new target membrane (Mizuno-Yamasaki, 2012).  The GEF is also used 
to target Rab proteins to the membrane.  It is hypothesized that the Rab binds non-specifically to 
the membrane multiple times until it meets the proper GEF that allows it to remain on the 
membrane for a longer period (Barr, 2012). Rab proteins tend to be activated in their GTP bound 
state.  This has been seen in a yeast Rab5/Vps21p tethering study where the interaction required 
the GTP-loaded form (Lo et. al 2012).  However, in a further study of human Rab proteins, three 
Rab proteins (Rab2a, Rab5a and Rab7a) were found to have activity (measured through liposome 
aggregation) without any nucleotide and adding GTP or GDP did not significantly change this 
activity (Tamura, 2014).  
Rab proteins are very ubiquitous, with over 8,000 Rab proteins occurring in 247 different 
genomes.  There are 44 subfamilies in humans,  55 in P. patens, and 11 in yeast (Ciencia, 2011).  
The RabA family in moss is hypothesized to bind to myosin XIa due to its homology to the 
mammalian Rab in this interaction. The RabA phylogeny tree is shown in Figure 3 (Agar, 2013). 
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Representative Rabs from three of the RabA subfamilies (RabA2, RabA4, RabA5) were 
chosen for future analysis. Previous studies show each of the Rabs highlighted localizes to the tip 
of a moss cell, and so are potential candidates for binding to myosin XIa (Callahan, 2014). 
1.6 KNOWN INTERACTIONS BETWEEN RABS AND MYOSIN 
The interactions between Rab GTPases and class V myosins have been previously 
studied using both S. cerevisiae and mammalian cells. The yeast and mammalian homologues, 
Myo2p and myosin V respectively, have both been crystallized, suggesting a putative binding 
region for Ypt31/32p or Rab11 respectively (Pashkova et al., 2006; Pylypenko, 2013). It is 
Figure 3: Phylogeny of the aligned RabA family from A. thailiana and  P. patens 
Representative P.patens Rab proteins used in this project are boxed in red (Agar, 2013) 
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hypothesized that the P. patens protein myosin XIa GTD analogously interacts with a RabA to 
facilitate polarized growth in vivo. 
1.6.1 Myo2p and Ypt31/32p in Yeast 
In 2006 the crystal structure of the globular tail domain of the yeast protein, Myo2p,  was 
determined by the Weisman lab; this was the first structure of a class V myosin GTD to be 
published (Pashkova et al., 2006). The yeast Myo2p GTD was found to consist of 15 alpha 
helices that form two densely packed subdomains as shown in Figure 4. This study also revealed 
highly conserved regions on opposite surfaces of the GTD that, when mutated, specifically 
disrupted either secretory vesicle inheritance or vacuole inheritance.  
 
 
Figure 4: Structural overview of the Myo2p GTD  A) Ribbon representation of crystal structural from 
two orientations B) Topology diagram of two subdomains (Subdomain I is blue and Subdomain II is red) 
(Pashkova et al., 2006) 
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 In a later publication, researchers found that the five mutations that created a deficiency 
in secretory vesicle inheritance did so by disrupting the binding site of either Ypt31 or Ypt32, the 
Rab11 homologues in yeast. Furthermore, the direct interaction of GTP-Ypt31/32p and Myo2-
GTD is essential for the polarization of Myo2p to sites of cell growth and cell viability. The 
specific interaction between Ypt31/32p and the Myo2-GTD was identified using a yeast two 
hybrid screen, and the nucleotide state was confirmed using Ypt31/32p mutants that were 
constitutively active or dominant negative (Lipatova et al., 2008). 
1.6.2 Myo5B and Rab11 in Mammalian Cells 
The homologous interaction between a mammalian motor (Myo5B) and a Rab GTPase 
(Rab11) was also recently studied.  In 2013, researchers solved the crystal structures of the 
Myo5B GTD, as well as Myo5B-GTD in complex with both activated and inactivated Rab11 
(Pylypenko, 2013).  The Myo5B-GTD in complex with Rab11-GTP is shown in Figure 5.  
Figure 5: Crystal structure of Rab11-GTP (grey) bound to Myo5B-GTD (red) 
(Pylypenko, 2013) 
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As seen in Figure 5, Myo5B binds Rab11 on the side of subdomain II, composed primarily 
of Helix 8 as well as portions of Helices 9 and 10 and the loop connecting H5 and H6. By 
comparing crystal structures of the activated and inactivated forms of Rab11, researchers showed 
that Rab11, in its active GTP-loaded form, binds to the GTD inducing a dramatic conformational 
change. This change blocks the hydrolysis of the gamma phosphate of the nucleotide, promoting 
a stable and direct interaction between the Rab and the motor.  
As in the yeast studies, several residues on the Myo5B GTD were identified as necessary for 
Rab11-GTP binding. Several residues were conserved between the yeast and mammalian 
systems. The residues which disrupted binding are summarized in Figure 6.  
Figure 6: Schematic view of the Rab11–GTP–Myo5B interactions  (Pylypenko, 2013) 
Mutations in the underlined residues result in Rab binding deficiency. Residues conserved between 
yeast Myo2p and vertebrate Myo5B, as well as residues conserved within Rabs, are labeled in 
black. Hydrophobic contacts are shown as dashed lines, hydrogen bonds as double lines. The 
residues that do not form interactions in the Rab11–GDP to Myo5B interface are highlighted in 
yellow. 
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These high resolution crystal structures and the data regarding conserved binding residues served 
as the basis for the mutant analysis of myosin XIa.  
1.6.3  Other Factors Effecting Myosin-Rab Binding 
 Several other components, including adaptor proteins and vesicle lipid composition have 
been found to affect interactions between myosin motors and Rab GTPases. For example, several 
adaptor proteins have been identified as interacting with Rab11. In 2002, a group of Drosophila 
researchers showed that the Rab11-myosin V interaction is mediated by a protein called dRip11 
(Drosophila Rab11 interacting protein). dRip11 participates in rhodopsin transport in developing 
photoreceptors through a direct and stabilizing interaction between both Rab11 and myosin V 
(Li, 2007). FIP2 has also been identified as a Rab11 adaptor in endosome recycling (Cullis, 
2002).  
 In addition to adaptor proteins, the lipid composition of vesicles has also been shown it 
affect Rab-Myosin interactions. For example, in budding yeast, phosphatidylinositol-4-phosphate 
(PI4P) is important for the Myo2p dependent trafficking of secretory compartments. In a 2011 
study, researchers showed the PI4P was not only present in late secretory compartments, but also 
critical for the association of the secretory compartments with Myo2p. In fact, enhancement of 
the interaction of PI4P and Myo2p removed the need for any interaction with the GTPases 
Ypt31/32p and Sec4p for proper secretory compartment transport. The interaction between PI4P 
was itself mediated by an unknown adaptor protein (Santiago-Tirado et al., 2011).  
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1.6.4 Mutagenesis Strategy in Myosin XIa 
In a previous study in the Vidali lab, nine potential binding sites of the Rab11 homolog were 
identified on the myosin XIa surface through a comparison to a model based on Myo2p from 
yeast. The hydrophobic residues that were spatially similar to the Myo2p disruption-of-binding 
residues were changed to arginines to disrupt binding.  These mutants were then screened 
through a mutant complementation assay (Armstrong, 2012). Myosin XIa and b were knocked 
down in P. patens, by targeting the UTR regions.  This causes small round plants with disrupted 
polarized growth (Figure 7, top middle panel).  This phenotype can be rescued with the addition 
of a plasmid containing the wild type gene (without the UTR) (Figure 7).  Plasmids expressing 
mutant myosin XIa proteins were tested to determine which mutants, if any, rescued the myosin 
XIa knockdown phenotype.  After seven days of growth the plants were imaged and compared.    
 
The three most severe phenotypes are shown in Figure 7 and were chosen for in-depth 
biochemical analysis. It is thought that the failure of these mutations to complement the loss of 
the wild-type protein are due to a disruption of the RabA-myosin XIa interaction. 
Figure 7: Lack of complementation of function using RNAi (Armstrong, 2012) 
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1.6.5 Modelling of Myosin XIa GTD 
The Myo5B GTD in complex with GTP-Rab11 crystal structure was published in 2013, 
providing more insight into the possible structure of myosin XIa when bound to a Rab 
(Pylypenko, 2013). Recent work in the lab (M. Dubuke, unpublished) used this new structure to 
update the model of the myosin XIa GTD, which was previously based upon the Myo2p 
structure (Pashkova et al., 2006). Figure 8 displays a structural alignment based on sequence 
homology of myosin XIa GTD to Myo5B GTD.  
 
 
 
 
 
 
 
 
Unlike Myo2p, the structure of Myo5B GTD was determined in complex with the Rab 
which allowed the modelling to make more accurate hypotheses about the structure of the 
myosin XIa globular tail domain when bound to Rab. This updated model, therefore, allowed the 
various residues on myosin XIa to be much more accurately located on the homology surface. 
The mutations previously identified and tested in the RNAi complementation assay (Armstrong 
2012) were mapped onto the surface of the Myo5B homology model, increasing the accuracy of 
Y1384R 
V1422R V1418R 
A B 
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their projected placement and orientation. Based on this model, residues 1384 and 1422 were 
predicted to be surface residues much like with the Myo2p modeling. Residue 1418, however, 
was predicted to be an internal hydrophobic residue. 
1.7 PURPOSE OF STUDY 
Polarized tip growth is an important process in many organisms.  In Physcomitrella patens, 
myosin XIa trafficking along actin is necessary for polarized growth (Vidali et al., 2010) and 
myosin XIa association with vesicles may have a regulatory effect on F-actin (Furt et al., 2013).  
In many other model systems, including yeast and mammalian systems, Rabs are needed to 
recruit specific cargo to the myosin cargo binding domain (Lipatova et al., 2008; Pylypenko, 
2013). It is therefore predicted that a Rab is necessary for recruitment of cargo to myosin XIa in 
P. patens. Based on homology to the mammalian Rab11, it is hypothesized that a RabA is 
binding myosin XIa to transport cargo needed for polarized growth. In previous studies, mutant 
myosin XIa proteins were determined to inhibit polarized growth through an RNAi 
complementation assay, and were predicted to disrupt myosin XIa RabA binding (Armstrong, 
2012). This study investigates which RabA binds to myosin XIa and if that binding is disrupted 
by the myosin XIa mutants from the RNAi complementation assay. 
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2.0 METHODOLOGY 
2.1 Q5 MUTAGENESIS 
Mutagenesis for the three selected myosin XIa mutants and three selected RabA21 
mutants was completed using the Q5 Mutagenesis Kit from New England Biolabs according to 
the company protocol (Catalog #: E0554S) The primers used are displayed in Table 1. 
Table 1: Primers for Q5 mutagenesis of myosin XIa and RabA21 
 
 Forward Primer Reverse Primer 
Myosin 
XIa 
Mutation 
ID 
Number 
Sequence 
ID 
Number 
Sequence 
V1418R WPI 157 
TATATCCGACAAGCACG
TGGATTTTTGGTCATTC
ATC 
WPI 147 
CTTGAGCTCATCCCATG
ACGCTCCAGCATACTC 
V1422R WPI 146 
GCAGTTGGATTTTTGCG
CATTCATCAAAAGCCA 
WPI 150 
TTGTCGGATATACTTGA
GCTCATCCCATGACGCT
CC 
Y1384R WPI 154 
TTTAGCAACGGAGAGCG
TGTGAAAGCTGGACTT 
WPI 158 
TGAGCAACACTCACGTC
TCAGCAGCAAACTGTT 
Rab A21 
Mutation 
ID 
Number 
Sequence 
ID 
Number 
Sequence 
S26N WPI 305 
CCGGTGTGGGGAAGAA
CAATCTGCTTTCCA 
WPI 306 
AATCTCCTATCAGCACC
ACCTTGAACAG 
Q71L WPI 307 
GGGACACAGCAGGGCT
AGAGAGGTACCGAG 
WPI 308 
AAATCTGAGCCTTGATC
GTCTTTCCATCGAC 
N125I WPI 309 
CATGCTGGTGGGGATCA
AGTCGGACCTGAA 
WPI 310 
ATCACAATGTTCGAGTC
CGCGTGGTCTC 
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12.5 µL of the Q5 master mix (Q5 Polymerase, Q5 Buffer, dNTPs), 10 µM of each 
primer, 1 ng of template DNA, and 9 µL of autoclaved H2O were combined in a thin walled PCR 
tube. The PCR was run for 25 cycles according to the Q5 protocol with an annealing temperature 
of 72°C and an extension time of 4 minutes. After the PCR, the presence of DNA was confirmed 
by running the sample on a 0.7% (w/v) agarose gel. 1 µL of PCR product was then added to 5 µL 
of KLD reaction buffer, 1 µL of KLD Enzyme Mix, and 3 µL of autoclaved H2O for ligation. 5 
µL of the product was then transformed into 50 µL of New England Biolabs 5α E. coli 
competent cells (Catalog #: C2987I) and plated on LB-carbenicillin (0.1 mg/ mL) selection 
plates.  
Colonies for each mutation were moved to a 3 mL liquid culture and grown overnight at 
37°C. Then, each culture was mini-prepped with a Qiagen kit (Catalog #: 27104). DNA samples 
were sent for sequencing to ensure the presence of the desired mutation and to check the fidelity 
of the Q5 polymerase.  
2.2 PROTEIN PURIFICATIONS 
2.2.1 Myosin XIa Coiled Coil Tail (CCT) Wild Type and Mutants 
BL21(DE3) or BL21(DE3) Codon+ RIL E. coli competent cells were transformed with 2 
μL of wild-type or mutant myosin plasmid (50-200 ng/µL), plated on LB plates with 0.1 mg/ml 
carbenicillin, and grown overnight at 37°C.  The subsequent colonies were added to a 50 mL 
starter culture of LB with 0.1 mg/mL ampicillin at 37°C, grown to an OD600 of about 1.0 and 
then split into the desired final culture volume (5-10 L) of LB with 0.1 mg/mL ampicillin at 
37°C.  When the OD600 was between 0.4 and 0.6, the cells were shifted to 15°C and induced with 
0.1 mM IPTG at an OD600 between 0.6-0.8. The cells were then grown overnight at 15°C. 
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After overnight growth, cells were harvested through centrifugation at 4°C at 5000 rpm 
for 10 minutes in a Sorvall Evolution centrifuge with a SLC-6000 rotor.  The supernatant was 
removed and the pellet was resuspended in 150ml of cold lysis buffer (50 mM NaH2PO4 pH 8.0, 
300 mM NaCl, 10mM imidazole, 10% (v/v) glycerol, fresh 5mM β-mercaptoethanol, 1mM 
PMSF, DNAse, and 1 Protease Inhibitor Tablet (Roche Diagnostics) added prior to lysis).  Then 
cells were lysed using a microfluizer cell disrupter (Microfluidics) at 80 psi.  Lysed cells were 
centrifuged at 13000 rpm in a Sorvall SS-34 rotor for 30 minutes at 4°C.   
The supernatant was added to 10 mL of Ni-NTA agarose bead slurry (Qiagen) pre-
equilibrated in cold lysis buffer.  The slurry then rocked on a nutator at 4°C for 60 minutes, and 
the bound beads were added to an empty gravity flow column at 4°C.  The column was washed 
with 50 mL of cold wash buffer (50 mM NaH2PO4 pH8.0, 300 mM NaCl, 20 mM imidazole, 
10% (v/v) glycerol, fresh 5 mM β-mercaptoethanol added prior to washing).  The protein was 
eluted off the beads into 1 mL fractions by filling the column with cold elution buffer (50 mM 
NaH2PO4, 300 mM NaCl, 250 mM imidazole, 10% (v/v) glycerol; pH8.0, fresh 5 mM β-
mercaptoethanol added prior to elution).  Fractions containing proteins were determined through 
spotting 5 μl of each fraction onto Wattman paper and staining with Coomassie Blue.  Protein-
containing fractions were pooled together and diluted to a 100 mM NaCl concentration in 
MonoQ Buffer A (10 mM Hepes pH 7.5, 10% (v/v) glycerol, 1 mM DTT).   
The protein was then loaded onto a MonoQ 10/10 column (GE LifeSciences) pre-
equilibrated in Buffer A (see above) with 10% (v/v) Buffer B (10 mM Hepes pH 7.5, 1 M NaCl, 
10% (v/v) glycerol, 1 mM DTT).  The column was eluted over a gradient of 10%-50% Buffer B 
over 20 column volumes with 2 mL fractions taken throughout.  A 12% SDS-PAGE gel was run 
with aliquots of fractions corresponding to A280 chromatograph peaks and stained with 
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Coomassie Blue; fractions containing myosin XIa were pooled together.  The protein was then 
concentrated using a Millipore Stirred Ultrafiltration with 25 mm Millipore Ultrafiltration 
Membranes with a 10,000 MW cut off, and buffer exchanged into 10 mM sodium phosphate pH 
7.4, 140 mM NaCl and 10% (v/v) glycerol buffer using a NAP 25 column (GE LifeSciences).  A 
ninhydrin assay was then performed to determine protein concentration (Rosen, 1957). 100 µL 
aliquots were frozen in liquid nitrogen and then stored at -80°C. 
2.2.2 Rab GTPases Wild Type and Mutants 
Proteins were expressed as described for myosin XIa above. After overnight growth, cells 
were harvested through centrifugation at 4°C at 5000 rpm (Sorvall Evolution centrifuge with a 
SLC-6000 rotor) for 10 minutes.  The pellet from 250 mL of culture was resuspended in 15mL of 
lysis buffer (20 mM Tris pH8, 300 mM NaCl, 1 mM DTT). Then cells were lysed using a 
microfluizer cell disrupter at 80 psi.  Lysed cells were centrifuged at 13000 rpm for 30 minutes at 
4°C in a Sorvall SS-34 rotor.  50 µL of magnetic glutathione resin (Pierce) was added to the 
supernatant and rocked on a nutator for 90 minutes.  The beads were then centrifuged to the 
bottom of the tube and the supernatant removed.  Beads were washed 3-4 times with 500 µL 
buffer and separated into 3 tubes (~100 µL each) for nucleotide exchange. 10 µL of each RabA 
was added to a fourth tube, the liquid was removed and the beads were boiled in 10 µL 1x SDS 
dye for 5 minutes.  7.5 µL was then run on a gel to determine the concentration based on a 
myosin XIa standard. 
10 µL of 0.1 M GDP (in diH2O) was added to one tube and 10 µL of 0.1 M GTPimido (in 
diH2O), a non-hydrolysable isoform GTP, was added to the second. 5 µL of binding buffer (10 
mM NaHPO4 pH 8, 140 mM NaC1, 10% (v/v) glycerol, 1 mM DTT, 1 mM EDTA, 5 mM 
MgCl2) was added to the last tube to generate an apo or non-nucleotide loaded form. The tubes 
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were then nutated overnight and washed into binding buffer (see above) to a final volume of 100 
µL. 
2.3 BINDING STUDIES 
2.3.1 Twelve Point Binding Curves 
After overnight nucleotide loading, pre-equilibrated GST-Rab bound magnetic resin was 
added into binding buffer (10 mM NaHPO4, pH 8; 140 mM NaCl; 10% glycerol; 1 mM DTT; 1 
mM EDTA; 5 mM MgCl2) and aliquoted in 12 Eppendorf tubes such that each of the 12 tubes 
had the same concentration of GST-Rab. The amount of beads was also standardized by diluting 
more concentrated Rab purifications into buffer-washed empty beads.  The liquid was then 
removed from each tube after magnetic separation (NEB, Catalog #: S1506S), leaving GST-Rab 
magnetic resin with no visible liquid.  Myosin XIa was serially diluted using binding buffer from 
32 µM to 0.03 µM, to obtain 12 different concentrations. 30 µL of myosin XIa dilution were 
added to each of the tubes of GST-Rab magnetic resin and 30 µL binding buffer was added for 
the 0 µM point. Tubes were incubated on a nutator at 4°C for one hour. Beads were spun down 
in a table top centrifuge and all the liquid was removed. Beads were washed in 60 µL of binding 
buffer zero to three times, depending on the experiment. All liquid was then removed and beads 
were resuspended in SDS loading dye (2% (w/v) SDS; 2 mM DTT; 4% (v/v) Glycerol; 0.04 M 
Tris-HCL pH=6.8; 0.004% (w/v) bromophenol blue) according to Table 2.  
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Table 2: Concentration of myosin XIa and volumes added in 12 point binding studies 
 
After samples were boiled in dye, 7.5 µL from each tube was loaded on a 10% SDS page 
gel and run at 100 V through the stacking gel, and then 200 V through the resolving gel. Gels, 
were krypton stained (Pierce, Catalog #: 46630).  Gels were imaged using a fluorescence reader 
(GE LifeSciences) for Alexa Fluor-532 and a PMT of 600.  Results were quantified by 
densitometry of the bands to find the fluorescence  (
𝑖𝑛𝑡𝑒𝑛𝑠𝑖𝑡𝑦 𝑜𝑓 𝑏𝑎𝑛𝑑−𝑏𝑎𝑐𝑘𝑔𝑟𝑜𝑢𝑛𝑑 𝑖𝑛𝑡𝑒𝑛𝑠𝑖𝑡𝑦
𝑎𝑟𝑒𝑎 𝑜𝑓 𝑏𝑎𝑛𝑑
) and 
normalized to a myosin standard (1.4 μg).  GraphPad PRISM was then used to fit a one site 
binding saturation curve to the data.  The equation was constrained with the background equal to 
zero as well as setting the maximum iterations between 1000 and 5000.   
2.3.2 12.5 nM Binding Study Methodology 
After overnight nucleotide loading, 12.5 nM of each Rab condition (GTP, GDP, apo) and 
GST were added to 4 tubes, and all liquid was removed from the tube.  Rabs were diluted in 
additional empty beads washed into binding buffer (10 mM NaHPO4, pH 8; 140 mM NaCl; 10% 
(v/v) glycerol; 1 mM DTT; 1 mM EDTA; 5 mM MgCl2; 0.5% (v/v) NP40) to keep the number 
of beads in each tube consistent.  Myosin XIa-CCT was diluted to final concentrations of 5 µM, 
2.5 µM and 0.25 µM with final concentrations of buffer components equal to those of the 
binding buffer.  Then 100 µL of each dilution of myosin XIa-CCT were added to each Rab 
[Myosin 
XIa] 
(µM) 
63.4 31.7 15.9 7.93 3.96 1.98 0.99 0.5 0.25 0.12 0.06 0 
1x Dye 
Added 
(µl) 
600 400 200 100 75 50 35 20 12 12 12 12 
22 
condition and GST alone, and allowed to nutate for 1 hour at 4°C.  Beads were spun down in a 
tabletop centrifuge and all the liquid from each tube was removed. 24 µL of 1x SDS dye was 
added to the each tube and spun down.  Samples were boiled for 7 minutes, and then spun again.  
Gels were ran and analyzed as in the binding curve methodology but instead of dividing 
by a standard, a molar ratio of myosin to the RabA or GST was calculated using the densitometry 
values normalized by each protein’s molecular weight.  These molar ratios were compared using 
an ANOVA with multiple comparisons to determine statistical significance. 
2.3.3 2.5 µM Binding Study 
Experiment was repeated as in 12.5 nM study, with 2.5 µM of each RabA protein and GST 
and only 5 µM myosin XIa.  After one hour nutation, beads were washed in 100 µL of binding 
buffer three times.  50 µL of dye was added after each reaction was complete and each sample 
was run on a 10 % SDS-PAGE gel.  A Western blot was performed by first transferring the 
proteins from the gel to a nitrocellulose membrane.  6 mL of PBS, 0.5% (v/v) Tween and 5% 
(w/v) milk was added to the nitrocellulose overnight to block the membrane. The next day, the 
membrane was incubated for one hour with a primary antibody, previously generated against the 
myosin XIa GTD, diluted in 6 mL final volume of PBS Tween at 1/500 final dilution.  The 
membrane was washed three times in PBS Tween, three times in PBS and three times again in 
PBS tween, with the third incubating for 30 minutes.  Next, a Goat anti-Rabbit secondary 
antibody diluted in PBS Tween at 1/1000 final dilution was added and nutated for 40 minutes.  
The wash protocol was repeated and then a 50:50 ratio of the Western blot detection reagents 
(Pierce, Catalog #: 21050) were added to the membrane for exactly 1 minute.  The membrane 
was then imaged using a chemiluminescence imager (GE LifeSciences).  Results were quantified 
as described in the binding curve protocol and analyzed for visual differences in the data.  
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3.0  RESULTS 
3.1 SITE DIRECTED MUTAGENESIS 
Both myosin XIa and RabA21 were mutagenized using the New England Biolabs Q5 
Mutagenesis Kit as described in the Methodology section. The myosin XIa mutations were made 
based on the results of the RNAi complementation assay (Figure 7) for use in future binding 
studies. The RabA21 mutants were created based on mutants described in Ypt31/32p from S. 
cerevisiae (Lipatova et al., 2008). These mutants were predicted to lock RabA21 in 
conformations analogous to a nucleotide state for use in binding studies (S26N and N124I are 
predicted to be dominant negatives and Q71L is predicted to be constitutively active).  
The PCR products obtained for each mutation were run on an agarose gel, shown below in 
Figure 9.   
Figure 9: PCR product from Q5 mutagenesis reactions for myosin XIa and RabA21 
6.9 kb 
7.7 kb 
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As shown in the figure, a PCR product with the expected size of 6.9 kb for myosin XIa and 
7.7 kb for Rab A21 was obtained for each mutant. After a gel purification step, each PCR 
product was used to transform E. coli and the presence of the mutation was confirmed in each 
plasmid via sequencing. The expression plasmids were then used to recombinantly express the P. 
patens proteins to be purified.  
3.2 PROTEIN PURIFICATIONS 
3.2.1 Wild type and Mutant Myosin XIa-CCT Purification 
 Plasmids containing each versions of the myosin XIa coiled-coil tail (CCT) construct (Wild 
type, Y1384, V1418R, V1422R) were transformed into BL21(DE3) E.coli competent cells and 
grown at 37°C to an OD600 of approximately 0.6. IPTG was then added, and induction proceeded 
overnight at 15°C.  Whole cell lysate was then purified through a nickel-NTA resin and then 
over an anion exchange column.  Fractions were collected and run on a 12% SDS PAGE gel, as 
shown in Figure 10.   
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V1422R and Y1384 were able to be purified similarly to the wild type, with the wild type 
having a higher yield due to a 10 L culture of E. coli as compare to a 5 L culture for each mutant 
(Figure 10, B and C). However, the V1418R mutant protein was unable to be successfully 
purified and came off the MonoQ uniformly (Figure D).  This is likely due to protein misfolding 
and forming insoluble aggregates both in the cell pellet during centrifugation and throughout the 
purification. This results is consistent with the Myo5B vs. myosin XIa modelling which 
predicted the residue to be internal.  
 The fractions containing each purified protein were then pooled and concentrated.  A 
ninhydrin assay was then performed to find the concentration of each protein, the results of 
which are shown in Figure 11. 
std 
Figure 10: Purification of myosin XIa (MW 58kDa) Upper Panel: MonoQ fractions on SDS-PAGE gel; 
Lower Panel: Chromatographs A) Wild Type (10 L) B) V1422R (5 L) C) Y1384R (5 L) D) V1418R (10L), 
Purified Myosin XIa Std. in first lane  
D 
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Figure 11: Myosin XIa ninhydrin assay   
 The concentrations were then calculated from the ratio of the leucine and myosin slopes in 
Figure 11. Wild type myosin was concentrated to 32 µM, V1422R was concentrated to 29.6 µM 
and Y1384R was concentrated to 12.99 µM.  These three proteins were then flash frozen with 
liquid nitrogen in 100 µL aliquots and stored at -80°C for future binding studies. 
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3.2.2 RabA21, A41, and A53 WT and RabA21 Mutants Purification 
 GST, wild type RabAs and RabA21 mutants were transformed into BL21(DE3) E.coli and 
grown at 37°C to an OD600 of approximately 0.6. IPTG was then added to induce the T7 
promoter, and induction proceeded overnight at 15°C.  The GST-Rabs were purified from whole 
cell lysate through a pull out with magnetic glutathione resin which were used in the binding 
studies.  To quantify the concentration of RabA or GST, a sample was taken and the beads were 
boiled in dye and run on an SDS-PAGE gel (Figure 12A).  Each RabA and GST migrated as 
expected on the gel to their respective sizes: RabA21 (51.6 KDa) RabA41 (52.3 KDa) RabA53 
(51.3 KDa) GST (26.3 KDa).  RabA21 mutants purified similarly to the wild type with a similar 
range of concentrations (Figure 12B).   
 Each RabA21 mutant had approximately the same molecular weight (51.5 kDa) and so ran 
to the same point in each lane. RabA and GST were freshly purified for each binding study, and 
concentrations ranged between 1-6 µM when compared to a myosin XIa standard.  The single 
step purification protocol, however, produced a somewhat impure sample as can be seen in the 
A B 
Figure 12: RabA wild type and mutant purification A) Representative gel of Wild 
type Rab and GST B) RabA21, RabA21 mutants and GST 
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many contaminant bands in Figure 12. Since the contaminants were consistent across the Rabs, 
the contaminants were accepted as background in all of the binding assays. 
3.3 RABA-MYOSIN XIA-CCT BINDING STUDIES 
Binding studies were performed to demonstrate a physical interaction between the purified 
myosin XIa-CCT and at least one of the RabA proteins which were purified. The three RabAs 
tested, RabA21, RabA41, RabA53, were chosen based on homology to the mammalian Rab11. 
Expected results included an increase in binding in the GTP-loaded form of the RabA, as seen by 
a lower Kd in binding curves or an increase in overall binding in the binding differentials 
experiments. These experiments allow for quantification of myosin XIa binding to Rab and could 
allow for the determination of the Kd. 
3.3.1 Binding Curve  
 A binding curve was created by performing a 12 point two-fold serial dilution of the wild 
type 32 µM myosin XIa-CCT and adding each concentration to 0.3 µM RabA-GST on 
glutathione resin. After one hour incubation, the liquid was removed, zero to three washes were 
performed (experiment dependent), and the remaining myosin was quantified on an SDS PAGE 
gel. Representative results for each of the three RabA proteins are shown in Figure 13. 
Figure 13: Twelve point binding curve experiments A) RabA21 B) RabA41 C) RabA53 
A B
 
C 
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A representative binding curve for each RabA is shown (Figure 13) in the GTP, GDP 
and APO nucleotide loaded state, along with a GST control.  RabA21 and RabA53 had myosin 
XIa binding around or above the level of binding to the GST control, while RabA41 was below 
the control for most concentrations tested. The data, however, were highly inconsistent and 
noisy, as can be seen in the major differences between the GST curves in each panel of Figure 
13. The variation in the data prevented the nonlinear regression software, GraphPad PRISM, 
from being able to accurately fit a binding curve to the data. These data suggest, however, that 
RabA21 and/ or RabA53 could be binding specifically to the myosin XIa-CCT, while RabA41 
likely does not have any specific binding. An approximate Kd for each RabA was determined to 
be in the low μM range, but no further precision was possible.  Optimization of the binding 
curves was needed for more conclusive results regarding a specific binding interaction between 
the myosin XIa and a RabA-GTP.  
3.3.2 Binding Differential (12.5 nM) 
As an attempt to minimize the noisiness of the data shown in Figure 13, the 
concentration of RabA in each condition was decreased to 12.5 nM and no washes were 
performed.  Additionally, instead of creating a binding curve using many protein concentrations, 
only three myosin XIa concentrations were used; a concentration near the approximate Kd (2.5 
μM) and concentrations above and below this concentration (5 and 0.25 μM).  While binding at 
the low and high concentrations of myosin XIa should show similar levels of myosin XIa 
binding to the RabA, points near the Kd should have greater differences in binding between the 
active and inactive state of the RabA and between the RabA proteins. Non-specific binding, 
however, should show no differences in binding between nucleotide state or Rab at a given 
concentration. The results from this binding experiment are shown in Figure 14. 
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As seen in Figure 14, RabA41 bound to myosin XIa significantly below the binding to 
GST, but RabA21 and RabA53 bound at or slightly above the binding to the GST control.  
Additionally, no significant differences were seen between the different nucleotide states, as 
would be expected based on previous knowledge of class V myosin and Rab interactions 
(Pylypenko, 2013).  While the concentration of RabA protein on the beads was decreased in an 
effort to minimize nonspecific binding, a possible cause of the variation in Figure 13, the 
specific signal was also greatly decreased in these experiments. Furthermore, at 12.5 nM RabA, 
any washing depleted the specific signal as well as nonspecific binding. Because specific signal 
was low due to the low concentration of Rab and nonspecific signal was high due to a lack of 
washes, the signal to noise ratio was too low to confidently draw conclusions from the data. 
Further work needed to be done to differentiate the binding between RabA21 and RabA53 and 
increase the signal to noise ratio.   
Figure 14: Binding differentials experiment (12.5 nM) A) RabA21 (n=6) B) RabA41 (n=3) C) RabA53 (n=6) 
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3.3.3 Binding Differential (2.5 µM) 
To overcome a potentially large off-rate of this reaction, the RabA concentration was 
increased to 2.5 μM and 5 μM myosin XIa was used.  This higher concentration was used to 
saturate the system, so that despite the potentially large off-rate of the reaction, there is enough 
RabA and myosin XIa to still have a percentage of the myosin XIa binding to the RabA. Having 
this saturation of the reaction allowed for the resin to be washed three times after nutation to 
minimize non-specific binding, but still have some of the specific binding remaining. The 
concentration of myosin XIa bound to the beads were then quantified by Western blot to be able 
clearly visualize the myosin XIa signal despite contaminants from the RabA purification (Figure 
15). 
 
A B 
Figure 15: Binding differentials experiment (2.5 μM) A) and B) display Western blots from RabA21 
(n=2), RabA41 (n=1), RabA53 (n=1) and GST (n=4).  Blots were performed using a myosin XIa 
antibody, which is quantified in C). Standard was 0.16 μM purified Myosin XIa.  
 
C 
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While RabA41 and RabA53 bound myosin XIa-CCT at or below the binding to the GST 
control, RabA21 GTP bound myosin XIa bound approximately three fold over the GST control 
and other nucleotide states. This data suggests that RabA21 GTP is binding to myosin XIa-CCT 
at a higher level than the other RabA proteins tested or the GDP state. However, the GST signal 
in these two trials greatly differed in intensity.  Since only one (RabA41 and RabA53) or two 
(RabA21) replicates were performed, this experiment would need to be repeated to be confirmed. 
3.3.4 RabA21 Nucleotide Locking  
Since the amount of successfully loaded nucleotide is unknown, RabA21 locked mutants 
were created and tested in the same protocol as the previous experiment. These mutants were 
modelled against the S. cerevisiae Ypt31/32p mutants to potentially induce a conformation 
change in Rab21 which is analogous to the nucleotide loaded states (S26N and N125I are 
predicted to be dominant negative and Q71L is predicted to be constitutively active). Therefore, 
the binding of Q71L-RabA21 should represent the binding if the GTP loading was perfectly 
efficient and be significantly above the GST control. The binding of S26N-RabA21 and N125I-
RabA21 should represent the binding in the inactive state of the Rab, and should be equivalent to 
the control. The experimental Western blots and their quantification can be seen in Figure 16. 
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No conclusions about the nucleotide state required for RabA21 binding to myosin XIa can 
be drawn from Figure 16. WT-RabA21 GTP had a higher signal than any of the mutants, 
including the hypothesized constitutively active mutant (Q71L).There was also large variation 
when two trials were performed with the dominant negative mutants (N125I and S26N), which 
would be expected from non-specific binding. However, due to the fact that the constitutively 
active mutant (Q71L) had lower binding than the dominant negative mutants (S26N and N125I) 
and the wild type RabA, these mutations are likely not properly locking the RabA into the proper 
nucleotide loaded conformation.  Due to the high concentration of RabA necessary and the yield 
limitations of the Rab purification protocol, the experiment was limited to only one (RabA21 
WT and Q71L) or two (S26N and N125I) trials.   Further work would be needed to characterize 
the true conformations of these mutants before they could be effectively used in future binding 
studies. 
  
Figure 16: Binding differentials (2.5 μM) RabA21 mutants A) and B) trial one and two of the RabA21 mutant study C) 
quantification of western blot data. Standard was 0.16 μM purified Myosin XIa. 
A B 
C 
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4.0  DISCUSSION 
Polarized tip growth is an important process in many organisms.  In Physcomitrella patens, 
myosin XIa trafficking along actin is necessary for polarized growth (Vidali et al., 2010). It is 
predicted that at least one RabA is necessary for recruitment of cargo to myosin XIa in P. patens, 
based on homology to the mammalian Rab11. In previous studies, mutations in myosin XIa 
proteins were determined to inhibit polarized growth through an RNAi complementation assay, 
and were predicted to disrupt myosin XIa RabA binding (Armstrong, 2012). This study 
investigated which RabA binds to myosin XIa and purified mutants from the RNAi 
complementation assay which could be disrupting the binding to a RabA.  
The results from the modeling and myosin XIa-CCT purification suggest that V1422R is 
most likely to be an exposed surface residue, which could have a phenotype due to disruption of 
the myosin-Rab binding interface. On the other hand, V1418R is likely an internal hydrophobic 
residue based on the modeling, which renders it insoluble in the purification.  
The described results indicate several conclusions regarding the interaction between myosin 
XIa and RabA21 in Physcomitrella patens. Firstly, the data in Figure 15 indicates that RabA21 
binds the globular tail domain of myosin XIa in its GTP-loaded form. This binding is in stark 
contrast to the interaction with RabA41, which does not physically associate with the myosin 
XIa-CCT in any of the binding assays performed.  
At this junction in the project, however, more work remains to be done in optimizing the 
binding studies between myosin XIa and RabA. While the data regarding the myosin XIa-
RabA21 interaction is promising, the data remains somewhat inconsistent and difficult to 
conclusively interpret. The variance in the data could be due to many reasons. Firstly, the 
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variation and relatively low binding affinity could be due to a mixed population of nucleotide 
state. If the current nucleotide exchange protocol does not efficiently strip the nucleotide in place 
at the time of purification and insert the desired nucleotide, this would result in mixed 
populations within a given experimental condition. This mixed population could then lead to 
only a small or varying percentage of RabA21molecules being in an active binding 
conformation, causing both apparently weak or the experimentally observed variance in binding. 
A variety of spectroscopic or biophysical approaches could be employed to identify the bound 
nucleotide in each RabA for future studies.  
Secondly, the binding studies could be optimized by attaching each of the RabAs to 
liposomes. Since Rab-GTPases are prenylated on their C-terminal domain, they efficiently 
embed into the membrane of cells (Mizuno-Yamasaki, 2012). Thus far, the recombinant RabAs 
have been GST-tagged on their N-terminus in an attempt to replicate the effect on the membrane. 
This method, however, likely poorly approximates the conformational changes associated with 
imbedding in the membrane, which could be inhibiting binding. By attaching each of the RabAs 
to liposomes and therefore introducing a bilayer membrane, the in vivo binding conditions may 
be more accurately replicated in vitro.  Since RabAs are embedded in the membrane in their 
active form, the membrane may have a role in binding, such as PI4P’s role in yeast (Mizuno-
Yamasaki et al., 2010; Santiago-Tirado et al., 2011). This has been done previously for human 
Rabs to determine their role in membrane tethering as well as endosomal tethering in yeast (Lo, 
2012; Tamura, 2014).      
Thirdly, the relatively low affinity of the RabA to myosin XIa could be due to the absence of 
an adapter protein. Other Rab-myosin interactions are mediated by additional proteins, such as 
mammalian Rab11-FIP2 which is implicated in the recycling of endosomes and receptor-
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mediated endocytosis and dRib11 which is important for rhodopsin transport (Cullis, 2002; Li, 
2007). An analogous system could be at work in P. patens where a RabA-myosin XIa interaction 
is stabilized or guided by an unknown adapter protein not present in the in vitro binding studies. 
One potential test for such an adapter protein could include a binding study with the addition of 
P. patens lysate. While this method eliminates much of the potential quantification power of the 
experiment, a significant increase in binding with the addition of lysate would suggest that the 
lysate contained an adapter necessary for efficient binding.  
Fourthly, the binding studies could be expanded to include many of the other RabAs present 
in P. patens. Thus far only three representative Rab-GTPases have been tested, but these may not 
be involved in physical interaction with myosin XIa. If the optimization steps previously 
described do not produce reproducible and significant results, the reason could be merely that the 
correct Rab binding partner has not yet been tested.  
Finally, if binding studies prove to be an ineffective means of identifying a Rab-myosin 
interaction in P. patens, other assays could be used to identify a physical interaction. Namely, 
mass spectrometry could be used to identify the proteins which bind to the CCT portion of 
myosin XIa. In this experiment, purified myosin XIa-CCT would be covalently attached to 
beads. P. patens cell lysate would then be incubated with the beads to allow binding to occur. 
After washing, all the proteins bound to the myosin XIa-CCT would be analyzed via mass 
spectrometry. Unlike the binding studies, this method allows for all the proteins in moss lysate to 
be analyzed at once for potential binding partners. Another potential experiment could utilize a 
yeast two hybrid screen using the myosin XIa cargo binding domain as bait. This strategy was 
successfully employed in Arabidposis thaliana to identify the myosin XIa receptor, but is also 
prone to both false positives and negatives (Peremyslov, 2013). 
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Once a myosin XIa-RabA interaction is confirmed, the myosin XIa mutants should be 
analyzed in the same method as the wild type myosin XIa.  If a defect in binding is observed 
with a mutant, this would support the hypothesis that the growth defect observed in the RNAi 
complementation assay for that mutant was due to an inhibition of binding with the Rab-GTPase. 
In the binding assay, this would manifest as an increase in the Kd and a decrease in overall 
binding. In the mass spectrometry assay, this would be seen by the RabA no longer being pulled 
down by the myosin XIa or being pulled down in decreasing quantities.  Ultimately, the P. 
patens myosin XIa-RabA interaction would be best characterized by solving the crystal structure 
of the proteins in complex with one another. This would clearly identify the binding interface on 
both binding partners and confirm the physical interaction between them. These types of 
experiments were employed successfully by the Weismann lab in the S. cerevisiae system with 
Myo2p and Ypt31/32p (Pashkova et al., 2006; Lipatova et al., 2008). 
Thus far, this research has demonstrated the promise in utilizing the tip cells of 
Physcomitrella patens to study the participation of myosin XIa in the complex processes of 
polarized growth. While more work needs to be done, RabA21-GTP has been identified as a 
viable candidate for a Rab-myosin interaction necessary for polarized growth.  
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